Literature DB >> 213390

Glycoproteins of natural origin with an affinity for hepatitis B surface antigen.

I Millman, J C McMichael.   

Abstract

Sera from certain animal species contain a substance(s) which binds hepatitis B surface antigen. The hepatitis B binding substance found in animals is not antibody, but appears to be a glycoprotein which reacted with antigen-coated beads and produced a "false positive" test for antibody. This glycoprotein could be selectively and quantitatively removed by reaction with purified hepatitis B surface antigen and centrifugation. Pili fractions isolated from Neisseria gonorrhoeae and Escherichia coli bound to hepatitis B surface antigen and produced false positive anti-hepatitis B surface antigen reactions. Mouse anti-bovine hepatitis B binding substance and rabbit anti-E. coli pili were capable of neutralizing bovine hepatitis B binding substance.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 213390      PMCID: PMC422079          DOI: 10.1128/iai.21.3.879-885.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  PURIFICATION AND PROPERTIES OF PORCINE SUBMAXILLARY MUCIN.

Authors:  Y HASHIMOTO; S HASHIMOTO; W PIGMAN
Journal:  Arch Biochem Biophys       Date:  1964-02       Impact factor: 4.013

2.  Studies on mucoproteins. IV. The linkage of the prosthetic group to the protein core in ovine submaxillary gland mucoprotein.

Authors:  A GOTTSCHALK; W H MURPHY
Journal:  Biochim Biophys Acta       Date:  1961-01-01

3.  The structure of the prosthetic group of bovine submaxillary gland mucoprotein.

Authors:  A GOTTSCHALK
Journal:  Biochim Biophys Acta       Date:  1957-06

4.  A mucoprotein from bovine submaxillary glands with restricted inhibitory action against influenza virus haemagglutination.

Authors:  C C CURTAIN; J PYE
Journal:  Aust J Exp Biol Med Sci       Date:  1955-06

5.  Studies on influenza virus receptor-substance and receptor-substance analogues. I. Preparation and properties of a homogeneous mucoid from the salivary gland of sheep.

Authors:  J F McCREA
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

6.  Carbohydrate residue of a urine mucoprotein inhibiting influenza virus haemagglutination.

Authors:  A GOTTSCHALK
Journal:  Nature       Date:  1952-10-18       Impact factor: 49.962

Review 7.  The structure, function, synthesis and genetic control of bacterial pili and a molecular model for DNA and RNA transport in gram negative bacteria.

Authors:  C C Brinton
Journal:  Trans N Y Acad Sci       Date:  1965-06

8.  Reaction between concanavalin A and the Australia antigen.

Authors:  L P Cawley
Journal:  Am J Clin Pathol       Date:  1972-02       Impact factor: 2.493

9.  Interaction of hepatitis B surface antigen (Australia antigen) with membrane vesicles of Pseudomonas aeruginosa.

Authors:  L K Weng; M E Bayer; W T London
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

10.  NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION.

Authors:  D S KELLOGG; W L PEACOCK; W E DEACON; L BROWN; D I PIRKLE
Journal:  J Bacteriol       Date:  1963-06       Impact factor: 3.490

View more
  5 in total

Review 1.  The underlying mechanisms for the "simultaneous HBsAg and anti-HBs serological profile".

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

2.  Serum iron levels and response to hepatitis B virus.

Authors:  C Felton; E D Lustbader; C Merten; B S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

3.  Hepatitis B surface antigen and polymerized albumin binding activity in sheep serum.

Authors:  S G Franklin; I Millman; B S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

4.  Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies.

Authors:  P S Venkateswaran; I Millman; B S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

5.  Long-term outcomes of HBsAg/anti-HBs double-positive versus HBsAg single-positive patients with chronic hepatitis B.

Authors:  Min-Sun Kwak; Goh-Eun Chung; Jong In Yang; Jeong Yoon Yim
Journal:  Sci Rep       Date:  2019-12-19       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.